TransCure is proud to serve researchers in the field by providing suitable HIV mouse disease models Scientists have long tried to duplicate the procedure… Read More »New H.I.V. long-term remission reported in a second patient, a huge milestone in the Global AIDS Epidemic
One more time, Labiotech speaks about TransCure bioServices! Find out more about how TransCure improves immuno-oncology research with its humanized mouse model. “The main… Read More »They talk about us in Labiotech – Immuno-Oncology
How TransCure improves data quality and animal welfare with a microchip-based identification system At TransCure bioServices, we are constantly looking for cutting-edge technologies to help… Read More »Our New Microchip Mouse Identification System
Targovax published efficacy data using TransCure’s full human immune system hu-mouse models. Targovax (OSE:TRVX) is a clinical stage biotechnology company developing immune activators to… Read More »TransCure bioServices involved in Targovax’s results
2018 Nobel Prize in Medicine Awarded to Cancer Immunotherapy Research James P. Allison and Tasuku Honjo were recognized for a discovery that the body’s… Read More »2018 Nobel Prize in Medicine: Reaction from our CEO
Dr. Poskin will lead the effort to achieve AAALAC accreditation AAALAC accreditation is a process that demonstrates the use of high standards and state… Read More »TransCure bioServices Hires Antoine Poskin, Veterinarian, PhD
Find more about TransCure’s humanized mice models which make it possible to test novel anti-HIV treatments on infected animal models with a fully functional… Read More »Labiotech: Can Humanized Mice Help Find a Cure for HIV?
